TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm

Report Cites TCS’ Significant Industry Expertise and Wide Range of Capabilities as Key Leadership Characteristics

Mumbai, February 28, 2013: Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading IT services, consulting and business solutions organization, announced that it has been designated as a Leader in Life Science Drug Safety Services (DSS) by the prominent global market intelligence firm IDC. Among the attributes that earned TCS its leadership position in the “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment” (Document # HI239221) are the company’s significant industry expertise, strong drug safety IT and KPO delivery capabilities and investment in drug safety specific IP assets.

IDC MarketScape reports are designed to identify factors conducive to success in a particular market, both long term and short term, and then assess vendors participating in the market against these factors. The criteria for each IDC MarketScape report is developed by IDC analysts and can include discussions, surveys and interviews. For this report, the key criteria for defining excellence included the following:

Breadth of service offerings
Diversity of resources and infrastructure-supporting services delivery
Project experience in the Life Sciences DSS outsourcing market
Customer service strategy and customer satisfaction
Pricing model
Go-to-market capabilities
Commitment to growth and innovation in the R&D DSS space

“TCS’ large life science customer base, broad industry-centric services portfolio, competitive pricing and strong commitment to growth ensure that the company will continue to be a leading service provider to the industry over both the near and long term,” said the report’s author, Alan S Louie, PhD, Research Director, Clinical Development Strategy and Technology, IDC Health Insights.

“For TCS and our life sciences customers, patient safety is the absolute priority and we are honored to be listed as a Leader by IDC Health Insights in the drug safety market,” said Debashis Ghosh, President, Life Sciences, Manufacturing and Energy, TCS.” This recognition is a testament to our commitment to our customers, of constantly innovating and delivering superior drug safety services, and helping companies in ensuring enhanced care for their patients.”

“To be named as a Leader in the drug safety market by IDC Health Insights is indeed a recognition of our differentiated strategy of providing core business services by investing in deep domain expertise and regulatory knowledge. TCS’ market leading capabilities in the drug safety space, including adverse event tracking and aggregate reporting, help the pharmaceutical industry meet their compliance requirements more effectively,” said Abid Ali Neemuchwala, Global Head, TCS’ BPO Services.

TCS’ drug safety services help customers enhance efficiency, reduce costs significantly and ensure regulatory compliance. TCS’ customers benefit from the company’s domain knowledge, global reach, quality systems approach, multi-disciplinary safety expertise and adherence to reporting timelines of the EMEA, FDA, MHRA and other industry authorities.

About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.

About TCS’ Life Sciences Services
Top global life sciences organizations derive value from TCS’ full services play in IT, consulting, KPO, infrastructure and engineering services as well as new-age business solutions including mobility and Big Data. TCS’ rich industry experience, domain expertise and global footprint ensures that it partners with its life sciences customers to help them advance clinical trial efficiencies, accelerate drug discovery, maximize manufacturing productivity and improve sales and marketing effectiveness. In addition, TCS has a dedicated Life Sciences Innovation Lab, which ensures that its customers have the tools and innovative solutions they need to solve complex business challenges.

About TCS’ Business Process Services
TCS’ Business Process Services are about managing and executing business operations. Our domain expertise helps deliver core business processing across industries, analytics and insights, and support processes such as accounting, HR and supply chain management. TCS partners with customers to accelerate co-transformation and generates business value for customers through delivery excellence, risk management and innovative models such as Platform BPO, which deliver process as a service. With over $1.4 billion in BPO revenues and 45,000+ employees across 11 countries delivering services to more than 225+ customers, TCS is one of the leading global domain-based BPO providers.

About Tata Consultancy Services Ltd. (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT, BPS,infrastructure, engineering and assurance services. This is delivered through its unique Global Network Delivery Model™,recognized as the benchmark of excellence in software development. A part of the Tata group, India’s largest industrial conglomerate, TCS has over 300,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $13.4 billion for year ended March 31, 2014 and is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit us at www.tcs.com.